Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1861 publications

Takotsubo Syndrome Following Combination Therapy with Dabrafenib and Trametinib: Case Report.

Takotsubo Syndrome Following Combination Therapy with Dabrafenib and Trametinib: Case Report.

Journal: Internal medicine (Tokyo, Japan)
Published: September 18, 2025

The Utility of Tissue-Agnostic Drugs in Lung Cancer Treatment.

The Utility of Tissue-Agnostic Drugs in Lung Cancer Treatment.

Journal: Pharmaceutical medicine
Published: August 26, 2025

Two Cases of BRAF V600K Melanoma With Recurrence During Adjuvant Dabrafenib Plus Trametinib Therapy.

Two Cases of BRAF V600K Melanoma With Recurrence During Adjuvant Dabrafenib Plus Trametinib Therapy.

Journal: The Journal of dermatology
Published: August 25, 2025

Immunotherapy in Melanoma.

Immunotherapy in Melanoma.

Journal: Cancer treatment and research
Published: August 23, 2025

LINC00313 functions as an oncogenic propellant and immunosuppressive marker in lung adenocarcinoma.

LINC00313 functions as an oncogenic propellant and immunosuppressive marker in lung adenocarcinoma.

Journal: Future science OA
Published: August 21, 2025

Loss of tumor cell MHC Class II drives MAPK-inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers.

Loss of tumor cell MHC Class II drives MAPK-inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers.

Journal: The Journal of clinical investigation
Published: August 19, 2025

Dabrafenib as a Therapeutic Option for Chemotherapy-Refractory Pediatric Juvenile Xanthogranuloma.

Dabrafenib as a Therapeutic Option for Chemotherapy-Refractory Pediatric Juvenile Xanthogranuloma.

Journal: Pediatric blood & cancer
Published: August 16, 2025

Treatment-Related Adverse Events in Individuals with BRAF-Mutant Cutaneous Melanoma Treated with BRAF and MEK Inhibitors: A Systematic Review and Meta-Analysis.

Treatment-Related Adverse Events in Individuals with BRAF-Mutant Cutaneous Melanoma Treated with BRAF and MEK Inhibitors: A Systematic Review and Meta-Analysis.

Journal: Cancers
Published: August 13, 2025

BRAF V600E-Mutant Diffuse Pulmonary Langerhans Cell Histiocytosis Successfully Treated With Dabrafenib Plus Trametinib: A Case Report.

BRAF V600E-Mutant Diffuse Pulmonary Langerhans Cell Histiocytosis Successfully Treated With Dabrafenib Plus Trametinib: A Case Report.

Journal: Respirology case reports
Published: August 12, 2025

Postmarket review of photosensitivity associated with select BRAF and MEK inhibitors.

Postmarket review of photosensitivity associated with select BRAF and MEK inhibitors.

Journal: Journal of chemotherapy (Florence, Italy)
Published: August 01, 2025

Combining Molecular Dynamics and Machine Learning to Predict Drug Resistance Causing Variants of BRAF in Colorectal Cancer.

Combining Molecular Dynamics and Machine Learning to Predict Drug Resistance Causing Variants of BRAF in Colorectal Cancer.

Journal: Molecules (Basel, Switzerland)
Published: July 18, 2025

Integrated In Silico and Experimental Validation of Antrocin as a Plant-Derived Multi-Target Therapeutic for BRAF/MEK/PI3K-Driven Colorectal Cancer.

Integrated In Silico and Experimental Validation of Antrocin as a Plant-Derived Multi-Target Therapeutic for BRAF/MEK/PI3K-Driven Colorectal Cancer.

Journal: International journal of molecular sciences
Published: July 17, 2025
Showing 1-12 of 1,861

Last Updated: 10/31/2025